Quick Answer
Neuraxis, INC reported Total Revenue of $3.57 million for fiscal year 2025.
Neuraxis, INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $3.57M +32.9% |
$2.69M +9.2% |
$2.46M -8.4% |
$2.68M | — |
| Revenue (ASC 606) | $3.57M +32.9% |
$2.69M +9.2% |
$2.46M -8.4% |
$2.68M | — |
| Net Income | -$7.80M +5.4% |
-$8.24M +43.7% |
-$14.63M -206.0% |
-$4.78M | — |
| Diluted EPS | -$0.95 +22.1% |
-$1.22 +72.9% |
-$4.50 -62.5% |
-$2.77 | — |
| Total Assets | $6.40M +34.6% |
$4.76M +284.9% |
$1.24M -16.5% |
$1.48M | — |
| Cash and Equivalents | $4.97M +34.3% |
$3.70M +385.6% |
$761.2K +200.1% |
$253.7K | — |
| Stockholders Equity | $3.40M +64.4% |
$2.07M +294.9% |
-$1.06M +81.0% |
-$5.57M -575.0% |
-$825.7K |
| R&D Expense | $493.6K +13.8% |
$433.6K +156.1% |
$169.3K -25.0% |
$225.6K | — |
| Operating Income | -$7.83M -9.4% |
-$7.16M -7.4% |
-$6.66M -97.6% |
-$3.37M | — |
| Gross Profit | $3.01M +29.4% |
$2.32M +7.8% |
$2.16M -9.7% |
$2.39M | — |
| Shares Outstanding | 10.65M +52.4% |
6.99M +7.4% |
6.51M +231.5% |
1.96M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $811.4K | +21.7% | -9.2% |
| Revenue (ASC 606) | September 30, 2025 | $811.4K | +21.7% | -9.2% |
| Net Income | September 30, 2025 | -$2.12M | -20.9% | -25.6% |
| Diluted EPS | September 30, 2025 | -$0.24 | +4.0% | -9.1% |
| Total Assets | September 30, 2025 | $5.78M | +405.2% | -18.5% |
| Cash and Equivalents | September 30, 2025 | $4.38M | +1577.8% | -26.9% |
| Stockholders Equity | September 30, 2025 | $2.28M | +227.4% | -46.3% |
| R&D Expense | September 30, 2025 | $130.8K | +3.6% | +124.4% |
| Operating Income | September 30, 2025 | -$2.10M | -27.2% | -22.3% |
| Gross Profit | September 30, 2025 | $675.9K | +18.7% | -9.6% |
| Shares Outstanding | September 30, 2025 | 9.89M | +41.6% | +0.3% |
- Neuraxis, INC reported Total Revenue of $3.57 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +32.9% in Total Revenue compared to the prior fiscal year.
- Neuraxis, INC reported Revenue (ASC 606) of $3.57 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +32.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Neuraxis, INC reported Net Income of -$7.80 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +5.4% in Net Income compared to the prior fiscal year.
- Neuraxis, INC reported Diluted EPS of $0.95 per share (loss) for fiscal year 2025.
- Neuraxis, INC showed an increase of +22.1% in Diluted EPS compared to the prior fiscal year.
- Neuraxis, INC reported Total Assets of $6.40 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +34.6% in Total Assets compared to the prior fiscal year.
- Neuraxis, INC reported Cash and Equivalents of $4.97 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +34.3% in Cash and Equivalents compared to the prior fiscal year.
- Neuraxis, INC reported Stockholders Equity of $3.40 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +64.4% in Stockholders Equity compared to the prior fiscal year.
- Neuraxis, INC reported R&D Expense of $493.6 thousand for fiscal year 2025.
- Neuraxis, INC showed an increase of +13.8% in R&D Expense compared to the prior fiscal year.
- Neuraxis, INC reported Operating Income of -$7.83 million for fiscal year 2025.
- Neuraxis, INC showed a decrease of -9.4% in Operating Income compared to the prior fiscal year.
- Neuraxis, INC reported Gross Profit of $3.01 million for fiscal year 2025.
- Neuraxis, INC showed an increase of +29.4% in Gross Profit compared to the prior fiscal year.
- Neuraxis, INC reported Shares Outstanding of 10.65 million shares for fiscal year 2025.
- Neuraxis, INC showed an increase of +52.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: